Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine dose-ranging crossover study in cold contact urticaria
2010-019344-39Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of bilastine in Cold urticaria (CU) (4 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Change in critical stimulation time threshold and Change in critical temperature threshold. Started Apr 2010; status: completed.
02
Drugs
bilastine
03
Conditions
Cold urticaria (CU)
Beyond the preview
Go deeper on 2010-019344-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019344-39.